Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up [Yahoo! Finance]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Yahoo! Finance
company, to develop and commercialize its only marketed product, Pedmark/Pedmarqsi (sodium thiosulfate injection), in EU, Australia and New Zealand. Fennec initially received FDA approval for Pedmark in 2022, granting marketing permission in the U.S. market as the first and only treatment to reduce the risk of ototoxicity (hearing loss) associated with cisplatin in pediatric patients aged one month and older with localized and non-metastatic solid tumors. The drug is also currently approved in the EU and the United Kingdom for the same indication as the United States in pediatric patients aged one month to 18 years under the brand name Pedmarqsi. The drug currently enjoys market exclusivity in the EU for 10 years. Per the terms of the licensing agreement, FENC is entitled to receive an upfront payment of €40 million from Norgine in consideration of the transfer of Pedmarqsi marketing rights. The company is eligible to receive up to €210 million in additional commercial and regul
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- Adma Biologics (ADMA) Stock Moves -0.31%: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why [Yahoo! Finance]Yahoo! Finance
- Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
- Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
- Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights [Yahoo! Finance]Yahoo! Finance
ADMA
Earnings
- 2/28/24 - Miss
ADMA
Sec Filings
- 4/15/24 - Form ARS
- 4/15/24 - Form DEFA14A
- 4/15/24 - Form DEF
- ADMA's page on the SEC website